Friedenthal Financial Makes New $54,000 Investment in DocuSign, Inc. (NASDAQ:DOCU)

Friedenthal Financial acquired a new stake in shares of DocuSign, Inc. (NASDAQ:DOCUFree Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 605 shares of the company’s stock, valued at approximately $54,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of DOCU. Itau Unibanco Holding S.A. purchased a new stake in DocuSign during the 3rd quarter valued at about $28,000. Brooklyn Investment Group bought a new position in shares of DocuSign in the third quarter worth approximately $33,000. Modus Advisors LLC purchased a new position in shares of DocuSign in the fourth quarter worth $36,000. Reston Wealth Management LLC bought a new stake in DocuSign during the 3rd quarter valued at $47,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in DocuSign during the 3rd quarter valued at $51,000. 77.64% of the stock is owned by institutional investors.

DocuSign Price Performance

NASDAQ:DOCU opened at $90.02 on Tuesday. The firm’s 50-day moving average price is $87.59 and its 200-day moving average price is $69.36. The company has a market capitalization of $18.19 billion, a PE ratio of 18.56, a P/E/G ratio of 8.70 and a beta of 0.88. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86.

Analyst Ratings Changes

Several equities analysts have recently commented on DOCU shares. JPMorgan Chase & Co. upped their price objective on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Tuesday, December 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday, December 6th. Wells Fargo & Company increased their price objective on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Friday, December 6th. Royal Bank of Canada restated a “sector perform” rating and set a $90.00 target price (up previously from $57.00) on shares of DocuSign in a report on Friday, December 6th. Finally, Jefferies Financial Group lifted their price target on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat, DocuSign currently has a consensus rating of “Hold” and a consensus price target of $92.45.

Read Our Latest Research Report on DOCU

Insider Buying and Selling

In other DocuSign news, CEO Allan C. Thygesen sold 7,764 shares of DocuSign stock in a transaction on Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the completion of the transaction, the chief executive officer now owns 107,825 shares in the company, valued at approximately $7,542,358.75. The trade was a 6.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel D. Springer sold 581,588 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the sale, the director now directly owns 906,430 shares in the company, valued at $87,959,967.20. This trade represents a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 693,537 shares of company stock valued at $66,575,817 over the last quarter. Corporate insiders own 1.66% of the company’s stock.

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.